close× Call Us 1(844) 401-0111
US Pointer Study

Can a healthy lifestyle protect memory in older adults?

We're looking for people ages 60 - 79 to participate in POINTER, a national clinical trial studying how healthy lifestyle interventions may support brain health and prevent cognitive decline.

Alzheimers

Join the Alzheimer's Prevention Registry

Become one of the 2,020 people helping us to make Alzheimer's history.

Amyloid

Drug Studied at Butler Hospital’s Memory and Aging Program May Become First New Treatment for Alzheimer’s in 16 Years

Aducanumab maker Biogen seeking FDA review in early 2020; Butler Hospital’s Memory and Aging program director Stephen Salloway optimistic about potential benefit for thousands of patients.

MAP-banner_periscope-trial

BAN2401 Clinical Trial Now Enrolling

Individuals with mild Alzheimer's disease may qualify to participate in a study to test an investigational medication aimed at slowing the progression of Alzheimer's disease.

A Worldwide Leader in Alzheimer’s Research

The Butler Hospital Memory & Aging Program (MAP) is a worldwide leader in Alzheimer’s disease research. Our cutting-edge research studies and clinical trials are aimed at developing new and better ways to detect, treat, and someday even prevent Alzheimer’s. Science is on the cusp of numerous breakthroughs in these areas; we’re proud to be playing a large role in those discoveries, and we’re excited about what they mean for bringing an end to Alzheimer’s in the future.

From participation in research, to volunteering, donating and spreading the word - see all the ways you can help “MAP an end to Alzheimer’s.”

Learn More

A Rhode Island Partner in The Treatment of Alzheimer’s Disease

An affiliate of The Warren Alpert Medical School of Brown University, MAP has a 25-year history of excellence in clinical care, training, and research. We are working hand in hand with community groups, health care providers, research organizations, and people like you to find preventative and breakthrough treatments for Alzheimer’s disease. Our success depends on the participation of people who are experiencing some degree of memory loss, as well as those with normal memory, in our research studies and clinical trials. And, it depends on the support and collaboration of the wider community.

Memory Matters Blog

Get the latest news about developments in the fight against Alzheimer’s and other memory disorders, find resources for patients and caregivers, and meet local Rhode Island Alzheimer’s heroes and pioneers.

Memory Matters Newsletter

Get the latest research news, local stories and resources delivered straight to your inbox each month.